234 related articles for article (PubMed ID: 28460643)
1. Regular and low-dose aspirin, other non-steroidal anti-inflammatory medications and prospective risk of HER2-defined breast cancer: the California Teachers Study.
Clarke CA; Canchola AJ; Moy LM; Neuhausen SL; Chung NT; Lacey JV; Bernstein L
Breast Cancer Res; 2017 May; 19(1):52. PubMed ID: 28460643
[TBL] [Abstract][Full Text] [Related]
2. Nonsteroidal anti-inflammatory drug use and breast cancer risk by stage and hormone receptor status.
Marshall SF; Bernstein L; Anton-Culver H; Deapen D; Horn-Ross PL; Mohrenweiser H; Peel D; Pinder R; Purdie DM; Reynolds P; Stram D; West D; Wright WE; Ziogas A; Ross RK
J Natl Cancer Inst; 2005 Jun; 97(11):805-12. PubMed ID: 15928301
[TBL] [Abstract][Full Text] [Related]
3. Aspirin use and risk of breast cancer in African American women.
Bertrand KA; Bethea TN; Gerlovin H; Coogan PF; Barber L; Rosenberg L; Palmer JR
Breast Cancer Res; 2020 Sep; 22(1):96. PubMed ID: 32887656
[TBL] [Abstract][Full Text] [Related]
4. Association of frequency and duration of aspirin use and hormone receptor status with breast cancer risk.
Terry MB; Gammon MD; Zhang FF; Tawfik H; Teitelbaum SL; Britton JA; Subbaramaiah K; Dannenberg AJ; Neugut AI
JAMA; 2004 May; 291(20):2433-40. PubMed ID: 15161893
[TBL] [Abstract][Full Text] [Related]
5. Regular use of aspirin and other non-steroidal anti-inflammatory drugs and breast cancer risk for women at familial or genetic risk: a cohort study.
Kehm RD; Hopper JL; John EM; Phillips KA; MacInnis RJ; Dite GS; Milne RL; Liao Y; Zeinomar N; Knight JA; Southey MC; Vahdat L; Kornhauser N; Cigler T; Chung WK; Giles GG; McLachlan SA; Friedlander ML; Weideman PC; Glendon G; Nesci S; ; Andrulis IL; Buys SS; Daly MB; Terry MB
Breast Cancer Res; 2019 Apr; 21(1):52. PubMed ID: 30999962
[TBL] [Abstract][Full Text] [Related]
6. Effect of aspirin and other NSAIDs on postmenopausal breast cancer incidence by hormone receptor status: results from a prospective cohort study.
Bardia A; Olson JE; Vachon CM; Lazovich D; Vierkant RA; Wang AH; Limburg PJ; Anderson KE; Cerhan JR
Breast Cancer Res Treat; 2011 Feb; 126(1):149-55. PubMed ID: 20669045
[TBL] [Abstract][Full Text] [Related]
7. Nonsteroidal anti-inflammatory drugs and breast cancer risk in the National Institutes of Health-AARP Diet and Health Study.
Gierach GL; Lacey JV; Schatzkin A; Leitzmann MF; Richesson D; Hollenbeck AR; Brinton LA
Breast Cancer Res; 2008; 10(2):R38. PubMed ID: 18447943
[TBL] [Abstract][Full Text] [Related]
8. Non-steroidal anti-inflammatory drugs (NSAIDs) and breast cancer risk: differences by molecular subtype.
Brasky TM; Bonner MR; Moysich KB; Ambrosone CB; Nie J; Tao MH; Edge SB; Kallakury BV; Marian C; Goerlitz DS; Trevisan M; Shields PG; Freudenheim JL
Cancer Causes Control; 2011 Jul; 22(7):965-75. PubMed ID: 21516318
[TBL] [Abstract][Full Text] [Related]
9. Recreational physical activity and risk of triple negative breast cancer in the California Teachers Study.
Ma H; Xu X; Clague J; Lu Y; Togawa K; Wang SS; Clarke CA; Lee E; Park HL; Sullivan-Halley J; Neuhausen SL; Bernstein L
Breast Cancer Res; 2016 Jun; 18(1):62. PubMed ID: 27317095
[TBL] [Abstract][Full Text] [Related]
10. Association of Analgesic Use With Risk of Ovarian Cancer in the Nurses' Health Studies.
Barnard ME; Poole EM; Curhan GC; Eliassen AH; Rosner BA; Terry KL; Tworoger SS
JAMA Oncol; 2018 Dec; 4(12):1675-1682. PubMed ID: 30286239
[TBL] [Abstract][Full Text] [Related]
11. Use of aspirin, other nonsteroidal anti-inflammatory drugs, and acetaminophen and postmenopausal breast cancer incidence.
Zhang X; Smith-Warner SA; Collins LC; Rosner B; Willett WC; Hankinson SE
J Clin Oncol; 2012 Oct; 30(28):3468-77. PubMed ID: 22927520
[TBL] [Abstract][Full Text] [Related]
12. Aspirin Treatment Effect and Association with PIK3CA Mutation in Breast Cancer: A Biomarker Analysis.
Zhou Y; Simmons J; Jordan CD; Sonbol MB; Maihle N; Tang SC
Clin Breast Cancer; 2019 Oct; 19(5):354-362.e7. PubMed ID: 31262687
[TBL] [Abstract][Full Text] [Related]
13. Novel polymorphisms in caspase-8 are associated with breast cancer risk in the California Teachers Study.
Park HL; Ziogas A; Chang J; Desai B; Bessonova L; Garner C; Lee E; Neuhausen SL; Wang SS; Ma H; Clague J; Reynolds P; Lacey JV; Bernstein L; Anton-Culver H
BMC Cancer; 2016 Jan; 16():14. PubMed ID: 26758508
[TBL] [Abstract][Full Text] [Related]
14. NSAIDs and breast cancer recurrence in a prospective cohort study.
Kwan ML; Habel LA; Slattery ML; Caan B
Cancer Causes Control; 2007 Aug; 18(6):613-20. PubMed ID: 17404892
[TBL] [Abstract][Full Text] [Related]
15. Reproductive characteristics, menopausal status, race and ethnicity, and risk of breast cancer subtypes defined by ER, PR and HER2 status: the Breast Cancer Etiology in Minorities study.
John EM; Koo J; Phipps AI; Longacre TA; Kurian AW; Ingles SA; Wu AH; Hines LM
Breast Cancer Res; 2024 May; 26(1):88. PubMed ID: 38822357
[TBL] [Abstract][Full Text] [Related]
16. Association of aspirin and nonsteroidal anti-inflammatory drug use with breast cancer.
Johnson TW; Anderson KE; Lazovich D; Folsom AR
Cancer Epidemiol Biomarkers Prev; 2002 Dec; 11(12):1586-91. PubMed ID: 12496048
[TBL] [Abstract][Full Text] [Related]
17. Relationship of established risk factors with breast cancer subtypes.
McCarthy AM; Friebel-Klingner T; Ehsan S; He W; Welch M; Chen J; Kontos D; Domchek SM; Conant EF; Semine A; Hughes K; Bardia A; Lehman C; Armstrong K
Cancer Med; 2021 Sep; 10(18):6456-6467. PubMed ID: 34464510
[TBL] [Abstract][Full Text] [Related]
18. Use of non-steroidal anti-inflammatory drugs and risk of breast cancer: The Spanish Multi-Case-control (MCC) study.
Dierssen-Sotos T; Gómez-Acebo I; de Pedro M; Pérez-Gómez B; Servitja S; Moreno V; Amiano P; Fernandez-Villa T; Barricarte A; Tardon A; Diaz-Santos M; Peiro-Perez R; Marcos-Gragera R; Lope V; Gracia-Lavedan E; Alonso MH; Michelena-Echeveste MJ; Garcia-Palomo A; Guevara M; Castaño-Vinyals G; Aragonés N; Kogevinas M; Pollán M; Llorca J
BMC Cancer; 2016 Aug; 16(1):660. PubMed ID: 27542890
[TBL] [Abstract][Full Text] [Related]
19. Associations of low-dose aspirin or other NSAID use with prostate cancer risk in the Danish Diet, Cancer and Health Study.
Skriver C; Dehlendorff C; Borre M; Brasso K; Larsen SB; Tjønneland A; Pottegård A; Hallas J; Sørensen HT; Friis S
Cancer Causes Control; 2020 Feb; 31(2):139-151. PubMed ID: 31823168
[TBL] [Abstract][Full Text] [Related]
20. Parity, hormones and breast cancer subtypes - results from a large nested case-control study in a national screening program.
Ellingjord-Dale M; Vos L; Tretli S; Hofvind S; Dos-Santos-Silva I; Ursin G
Breast Cancer Res; 2017 Jan; 19(1):10. PubMed ID: 28114999
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
